1yok: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1yok" size="450" color="white" frame="true" align="right" spinBox="true" caption="1yok, resolution 2.5Å" /> '''crystal structure of... |
No edit summary |
||
| (15 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== | ==crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol== | ||
<StructureSection load='1yok' size='340' side='right'caption='[[1yok]], [[Resolution|resolution]] 2.50Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[1yok]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YOK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1YOK FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=P6L:(2S)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(6E)-HEXADEC-6-ENOYLOXY]PROPYL+(8E)-OCTADEC-8-ENOATE'>P6L</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1yok FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1yok OCA], [https://pdbe.org/1yok PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1yok RCSB], [https://www.ebi.ac.uk/pdbsum/1yok PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1yok ProSAT]</span></td></tr> | |||
</table> | |||
== Disease == | |||
[https://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN] Note=Chromosomal aberrations involving NCOA2 may be a cause of acute myeloid leukemias. Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation. | |||
== Function == | |||
[https://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN] Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to control energy balance between white and brown adipose tissues.<ref>PMID:9430642</ref> | |||
== Evolutionary Conservation == | |||
[[Image:Consurf_key_small.gif|200px|right]] | |||
Check<jmol> | |||
<jmolCheckbox> | |||
<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/yo/1yok_consurf.spt"</scriptWhenChecked> | |||
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | |||
<text>to colour the structure by Evolutionary Conservation</text> | |||
</jmolCheckbox> | |||
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1yok ConSurf]. | |||
<div style="clear:both"></div> | |||
== | ==See Also== | ||
*[[Liver receptor homolog-1|Liver receptor homolog-1]] | |||
== References == | |||
== | <references/> | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Bynum | [[Category: Bynum JM]] | ||
[[Category: Fletterick | [[Category: Fletterick RJ]] | ||
[[Category: Guy | [[Category: Guy RK]] | ||
[[Category: Ingraham | [[Category: Ingraham HA]] | ||
[[Category: Juzumiene | [[Category: Juzumiene D]] | ||
[[Category: Krylova | [[Category: Krylova IN]] | ||
[[Category: Lebedeva | [[Category: Lebedeva L]] | ||
[[Category: MacKay | [[Category: MacKay JA]] | ||
[[Category: Madauss | [[Category: Madauss K]] | ||
[[Category: Montana | [[Category: Montana V]] | ||
[[Category: Moore | [[Category: Moore J]] | ||
[[Category: Sablin | [[Category: Sablin EP]] | ||
[[Category: Suzawa | [[Category: Suzawa M]] | ||
[[Category: Thornton | [[Category: Thornton JW]] | ||
[[Category: Waitt | [[Category: Waitt GM]] | ||
[[Category: Williams | [[Category: Williams JD]] | ||
[[Category: Williams | [[Category: Williams SP]] | ||
[[Category: Willson | [[Category: Willson TM]] | ||
[[Category: Xu | [[Category: Xu RX]] | ||
Latest revision as of 08:58, 14 February 2024
crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol
| ||||||||||||
